A qualitative study at St Anne's Mission Hospital in rural Zimbabwe finds that health workers value the Impilo electronic ...

Since its inception in 2020, Impilo has rapidly positioned itself at the forefront of healthcare innovation, using cutting-edge technology to eliminate the barriers to receiving care at home. In a ...

PHILADELPHIA, Jan. 16, 2025 /PRNewswire/ -- Impilo announces strategic integrations with A&D Medical, a 50-year pioneer in healthcare monitoring, and PatchRx, an innovative medication adherence ...

NEW YORK, June 16, 2025--(BUSINESS WIRE)--Ash, a leading at-home health testing platform, and Impilo, a leader in enabling at-home healthcare through its tech-enabled healthcare logistics and ...

PHILADELPHIA, April 17, 2025 /PRNewswire/ -- Impilo, a leader in enabling at-home healthcare through connected device and diagnostics operations, is excited to announce it has joined the Elation ...

PHILADELPHIA, Jan. 7, 2026 /PRNewswire/ -- Impilo, a leader in next-generation connected care solutions, today announced its strategic expansion of physical operations with new warehouse facilities in ...

– Impilo, a digital health platform revolutionizing healthcare access raises $11.5M in a Series A funding round led by Construct Capital, with participation from GC 1 Capital, One Way Ventures, 2048 ...

STOCKHOLM & LONDON--(BUSINESS WIRE)-- Investment funds managed by KKR, a leading global investment firm, have agreed to acquire Immedica Pharma, a pharmaceutical company headquartered in Stockholm, ...

Impilo and SHS have acquired Lowenco, a maker of ultra-low temperature storage solutions for the pharmaceutical industry. No financial terms were disclosed. Brown Gibbons Lang & Company was financial ...

Impilo has invested in a 29% stake in Cavidi AB, an Uppsala-based diagnostics company focused on HIV Viral Load monitoring. Cavidi has developed a new fully automated viral load diagnostic platform.

KKR has agreed to buy into Immedica Pharma, a pharmaceutical company focused on the commercialization of medicines for rare diseases and speciality care products. Immedica’s existing owner Impilo will ...